Frazier Life Sciences Public Fund, L.P. is > 10% Shareholder of Viridian Therapeutics, Inc.\DE. Currently has a direct ownership of 1.51 Million shares of VRDN, which is worth approximately $34.2 Million. The most recent transaction as insider was on Sep 23, 2021, when has been sold 200,000 shares (Common Stock) at a price of $11.0 per share, resulting in proceeds of $2,200,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.51M
0% 3M change
0% 12M change
Total Value Held $34.2 Million

Frazier Life Sciences Public Fund, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 23 2021
BUY
Open market or private purchase
$2,200,000 $11.0 p/Share
200,000 Added 11.73%
1,505,200 Common Stock
FLS

Frazier Life Sciences Public Fund, L.P.

> 10% Shareholder
Seattle, WA

Track Institutional and Insider Activities on VRDN

Follow Viridian Therapeutics, Inc.\DE and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRDN shares.

Notify only if

Insider Trading

Get notified when an Viridian Therapeutics, Inc.\De insider buys or sells VRDN shares.

Notify only if

News

Receive news related to Viridian Therapeutics, Inc.\DE

Track Activities on VRDN